Development and Validation of a Duplex Real-time PCR for the Rapid Detection and Quantitation of HTLV-1

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2023 Jan 17

PMID 36650537

Authors

Huimin Ji

Le Chang

Ying Yan

Lunan Wang

Affiliations

Soon will be listed here.

Abstract

Background: The HTLV-1 prevalence in China varies geographically, while HTLV-2 infection has rarely been found so far. Proviral load is one of the determining factors of pathogenesis and progression of HTLV-1 related diseases. However, neither molecular assays nor commercial kits are available for HTLV-1 diagnosis in China. The objective of the present study was to develop and validate a TaqMan qPCR assay for HTLV-1 proviral load quantification.

Results: A plasmid containing both the HTLV-1 of interest and a fragment of the RNase P (RPPH1) gene was constructed and used to establish the standard curves. The assay has a wide dynamic range (2.5 × 10 copies/reaction ~ 25 copies/reaction) and sensitive to 1 copy for HTLV-1 and RPPH1. The limit of detection for Hut102 cell concentration was 0.0218% (95% confidence interval 0.0179-0.0298%). The assay gave coefficient of variation (CV) for both the HTLV-1 and RPPH1 Ct values. All of the HTLV-1 sero-negative samples and MOT cell line (infected with HTLV-2) amplified only the RPPH1 gene by our method, presenting 100% specificity. 85 Samples confirmed positive or indeterminate by LIA were performed by established qPCR assay and WB. 90.0% (27/30) of LIA-HTLV-1-positive, 33% (2/6) of LIA-untypeable and 2% (1/49) of LIA-indeterminate samples were defined as qPCR-positive. The median PVL of LIA-positive samples (n = 27, 1.780 copies/100 cells) was much higher than that of LIA-untypeable and (n = 2, 0.271 copies/100 cells) indeterminate samples (n = 1, 0.017 copies/ 100 cells). Additionally, compared to WB, the duplex qPCR verified more positive samples, demonstrating a better sensitivity.

Conclusion: The duplex qPCR developed here with high sensitivity, good specificity and reproducibility could accurately and quantitatively detect the HTLV-1 PVLs, which can be used to confirm the initial reactive samples for an improved cost/benefit ratio as well as to monitor the clinical progression and efficacy of therapy in patients with HTLV-1 related disease.

Citing Articles

BLV-CoCoMo Dual qPCR Assay Targeting LTR Region for Quantifying Bovine Leukemia Virus: Comparison with Multiplex Real-Time qPCR Assay Targeting Region.

Watanuki S, Bao A, Saitou E, Shoji K, Izawa M, Okami M Pathogens. 2025; 13(12.

PMID: 39770370 PMC: 11677995. DOI: 10.3390/pathogens13121111.

Development of Dry and Liquid Duplex Reagent Mix-Based Polymerase Chain Reaction Assays as Novel Tools for the Rapid and Easy Quantification of Bovine Leukemia Virus (BLV) Proviral Loads.

Watanuki S, Shoji K, Izawa M, Okami M, Ye Y, Bao A Viruses. 2024; 16(7).

PMID: 39066179 PMC: 11281531. DOI: 10.3390/v16071016.

Genetic typing and intrafamilial transmission of human T-lymphotropic virus type 1 in non-endemic areas of China.

Ji H, Chang L, Yan Y, Sun H, Liu Y, Wang L Front Microbiol. 2023; 14:1288990.

PMID: 37920260 PMC: 10619906. DOI: 10.3389/fmicb.2023.1288990.

References

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K . Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results. J Clin Microbiol. 2017; 55(9):2838-2849. PMC: 5648719. DOI: 10.1128/JCM.00659-17. View

Moens B, Lopez G, Adaui V, Gonzalez E, Kerremans L, Clark D . Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol. 2009; 47(11):3682-91. PMC: 2772591. DOI: 10.1128/JCM.00781-09. View

Zhang K, Liu Y, Chen R, Li Q, Xu Z, Si L . Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection. J Med Virol. 2017; 90(2):263-270. DOI: 10.1002/jmv.24936. View

Chang L, Ou S, Shan Z, Zhu F, Ji H, Rong X . Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey. Retrovirology. 2021; 18(1):2. PMC: 7791705. DOI: 10.1186/s12977-020-00546-w. View

Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. PMC: 350514. DOI: 10.1073/pnas.77.12.7415. View

Paiva A, Casseb J . Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas. Rev Inst Med Trop Sao Paulo. 2015; 57(1):1-13. PMC: 4325517. DOI: 10.1590/S0036-46652015000100001. View

Costa J, Segurado A . Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil. J Clin Virol. 2009; 44(3):185-9. DOI: 10.1016/j.jcv.2008.12.015. View

Lee T, Chafets D, Busch M, Murphy E . Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004; 31(4):275-82. DOI: 10.1016/j.jcv.2004.05.016. View

Campos K, Santos F, da Silva Brito V, Goncalves N, Araujo T, Galvao-Castro B . Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil. J Clin Microbiol. 2019; 58(1). PMC: 6935901. DOI: 10.1128/JCM.01384-19. View

10.

Inaba S, Sato H, Okochi K, Fukada K, Takakura F, Tokunaga K . Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion. 1989; 29(1):7-11. DOI: 10.1046/j.1537-2995.1989.29189101168.x. View

11.

Rosadas C, Brites C, Arakaki-Sanchez D, Casseb J, Ishak R . Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection. Rev Soc Bras Med Trop. 2021; 54(suppl 1):e2020605. PMC: 8210483. DOI: 10.1590/0037-8682-605-2020. View

12.

Kuramitsu M, Okuma K, Tezuka K, Nakamura H, Sagara Y, Kurane I . Development and evaluation of human T-cell leukemia virus-1 and -2 multiplex quantitative PCR. Microbiol Immunol. 2019; 63(11):458-464. DOI: 10.1111/1348-0421.12740. View

13.

Goncalves M, Fukasawa L, Campos K, Takenori Higa F, Caterino-de-Araujo A . Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands. Front Microbiol. 2022; 13:831594. PMC: 8965094. DOI: 10.3389/fmicb.2022.831594. View

14.

Gallo R, Willems L, Hasegawa H . Screening transplant donors for HTLV-1 and -2. Blood. 2016; 128(26):3029-3031. DOI: 10.1182/blood-2016-09-739433. View

15.

Smith R, Niewiesk S, Booth S, Bangham C, Daenke S . Functional conservation of HTLV-1 rex balances the immune pressure for sequence variation in the rex gene. Virology. 1997; 237(2):397-403. DOI: 10.1006/viro.1997.8789. View

16.

Bandeira L, Puga M, de Paula V, Demarchi L, Lichs G, Domingos J . Use of synthetic oligonucleotides for determination of HTLV-1 proviral load by real-time PCR: a helpful alternative approach in the clinical management. J Appl Microbiol. 2020; 129(3):768-774. DOI: 10.1111/jam.14646. View

17.

Suzuki J, Kira J, Baba E, Nakamura M, Koyanagi Y, Nakamura T . The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 1996; 173(5):1115-22. DOI: 10.1093/infdis/173.5.1115. View

18.

Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K . Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996; 88(8):3065-73. View

19.

Zanjani D, Shahabi M, Talaei N, Afzalaghaee M, Tehranian F, Bazargani R . Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences. AIDS Res Hum Retroviruses. 2010; 27(2):131-5. DOI: 10.1089/aid.2010.0017. View

20.

Ji H, Chang L, Yan Y, Jiang X, Sun H, Guo F . A Strategy for Screening and Confirmation of HTLV-1/2 Infections in Low-Endemic Areas. Front Microbiol. 2020; 11:1151. PMC: 7283491. DOI: 10.3389/fmicb.2020.01151. View